Scientific work

Doç. Dr. Tülay Eren

80 publications. The source of the information is stated next to each publication.

Back to profile

  1. Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

    Current Oncology, 2026

    DOI 10.3390/curroncol33060365 PMID 42346265 Open-access full textSource: OpenAlex

  2. Impact of Prior mRNA COVID-19 Vaccination on PFS2 in NSCLC Patients Receiving Second-Line Immune Checkpoint Inhibitors: A Real-World Analysis

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15072475 PMID 41976774 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  3. Fear of Cancer Recurrence and Psychological Symptom Burden in Breast Cancer Survivors Without Evidence of Active Disease: A Cross-Sectional Real-World Study

    Healthcare (Basel, Switzerland), 2026

    DOI 10.3390/healthcare14162665 PMID 42651434 Open-access full textSource: Europe PMC

  4. Prognostic Significance of Lung Immune Prognostic Index at Diagnosis in Stage III Non-Small Cell Lung Cancer

    Current oncology (Toronto, Ont.), 2026

    DOI 10.3390/curroncol33010043 PMID 41590363 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  5. Independent factors associated with advanced testicular germ cell tumors: the roles of smoking, lymphovascular invasion, and tumor size

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-15598-y PMID 41555284 Open-access full textSource: OpenAlex

  6. Emergency Surgery Independently Predicts Postoperative Recurrence in Patients with Pathologic T3N0M0 Colon Cancer: A Retrospective Single-Center Cohort Study

    Current Oncology, 2026

    DOI 10.3390/curroncol33090526 PMID 42782872 Open-access full textSource: OpenAlex

  7. Association Between Smoking Status and PD-L1 Expression in Metastatic Driver Mutation Negative Non-Small Cell Lung Cancer: A Real-World Cohort Study

    Eurasian Journal of Medical Investigation, 2026

    DOI 10.14744/ejmi.2612473 Source: OpenAlex

  8. Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study

    Cancer Investigation, 2025

    DOI 10.1080/07357907.2025.2595536 PMID 41347635 1 citation (Europe PMC) Source: OpenAlex

  9. Could Sarcopenia Be Related to Chemotherapy in Gastrointestinal Cancer? A Cross-Sectional Study Including Comprehensive Geriatric Assessment

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14030711 PMID 39941382 4 citations (Europe PMC) Open-access full textSource: ORCID

  10. Health-related quality of life and psychosocial outcomes in long-term survivors treated with immune checkpoint inhibitors: a nationwide multicenter study

    Frontiers in Immunology, 2025

    DOI 10.3389/fimmu.2025.1693295 PMID 41451229 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  11. Prognostic Value of STAS, Lymph Node Metastasis, and VPI in NSCLC ≤ 4 cm Treated with Lobectomy

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm15010233 PMID 41517482 Open-access full textSource: OpenAlex

  12. Prognostic Value of Inflammatory Markers, CA 19-9, MELD Score, and ECOG in Stage 4 Gastric Cancer with Liver Metastases

    Acta haematologica oncologica Turcica., 2025

    DOI 10.4274/ahot.galenos.2025.2025-5-4 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  13. Do Inflammatory and Nutritional Markers Predict Prognosis in Metastatic Non-Small Cell Lung Cancer Patients Receiving Nivolumab

    Journal of inflammation research, 2025

    DOI 10.2147/jir.s541842 PMID 41209385 4 citations (Europe PMC) Open-access full textSource: Europe PMC

  14. Is Hemoglobin, Albumin, Lymphocyte, and Platelet Score a Prognostic Indicator in Metastatic Squamous Cell Lung Cancer?

    Acta haematologica oncologica Turcica., 2025

    DOI 10.4274/ahot.galenos.2025.2024-9-1 Open-access full textSource: OpenAlex

  15. Aggressive breast cancer in young women: Single-center experience

    Adıyaman Üniversitesi Sağlık Bilimleri Dergisi, 2025

    DOI 10.30569/adiyamansaglik.1587581 Open-access full textSource: OpenAlex

  16. Prognostic Value of the Hemoglobin, Albumin, Lymphocyte, Platelet Score in Metastatic Mesothelioma: A Retrospective Study

    Oncology, 2025

    DOI 10.1159/000547271 PMID 40628251 Source: OpenAlex

  17. Prognostic Factors and Treatment Outcomes in Pulmonary Adenoid Cystic Carcinoma

    Eurasian Journal of Medical Investigation, 2025

    DOI 10.14744/ejmi.2025.45789 Source: OpenAlex

  18. The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer

    Oncology, 2024

    DOI 10.1159/000540517 PMID 39079501 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  19. Factors affecting survival in patients undergoing percutaneous transhepatic biliary drainage for malignant biliary obstruction.

    PubMed, 2024

    DOI 10.26355/eurrev_202402_35484 PMID 38436188 2 citations (OpenAlex) Source: OpenAlex

  20. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

    BMC Cancer, 2023

    DOI 10.1186/s12885-023-10609-8 PMID 36765293 18 citations (Europe PMC) Open-access full textSource: OpenAlex

  21. Percutaneous ablation treatment in metastatic lung tumors: a single-center experience

    Acta Radiologica, 2023

    DOI 10.1177/02841851231175657 PMID 37246396 1 citation (Europe PMC) Source: ORCID

  22. The Incidental Diagnosis of Lung Cancer Through Chest Tomography During the COVID-19 Pandemic

    Journal of Oncological Sciences, 2023

    DOI 10.37047/jos.2023-98748 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  23. Second-line Chemotherapy in Advanced Gastric Cancer: Taxanes versus 5-FU-Based Treatment

    Journal of College of Physicians And Surgeons Pakistan, 2023

    DOI 10.29271/jcpsp.2023.07.770 PMID 37401218 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  24. Current Topics In Hemato-Oncology

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1576 Open-access full textSource: ORCID

  25. Evaluation of Blood Stream and Biliary Tract Infections Related to Percutaneous Transhepatic Cholangiography and Prophylaxis Given in Patients with Malignancy

    Infectious diseases & clinical microbiology, 2022

    DOI 10.36519/idcm.2022.176 PMID 38633711 Open-access full textSource: Europe PMC

  26. Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy

    Future oncology (London, England), 2021

    DOI 10.2217/fon-2021-0597 PMID 34342517 28 citations (Europe PMC) Open-access full textSource: Europe PMC

  27. The impact of lymph node ratio on overall survival in patients with colorectal cancer

    Journal of Cancer Research and Therapeutics, 2021

    DOI 10.4103/jcrt.jcrt_11_19 PMID 34528566 8 citations (Europe PMC) Open-access full textSource: ORCID

  28. Investigation of Hereditary Cancer Predisposition Genes of Patients with Colorectal Cancer: Single-centre Experience.

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2021

    DOI 10.29271/jcpsp.2021.07.811 PMID 34271781 5 citations (Europe PMC) Open-access full textSource: ORCID

  29. Satisfaction analysis of cancer patient, caregiver and nurse

    2021

    Source: OpenAlex

  30. BRCA1/2 normal meme kanserli kadınlarda genotip-fenotip ilişkisinin araştırılması: Türkiye'den tek merkez deneyimi

    Turkish Journal of Clinics and Laboratory, 2021

    DOI 10.18663/tjcl.948240 Open-access full textSource: OpenAlex

  31. “Swords and Shields” against COVID-19 for patients with cancer at “clean” and “pandemic” hospitals: are we ready for the second wave?

    Supportive Care in Cancer, 2021

    DOI 10.1007/s00520-021-06001-6 PMID 33479795 7 citations (OpenAlex) Open-access full textSource: OpenAlex

  32. The Real-Life Data of BRAF Mutation on the Treatment of Colorectal Cancer: a TOG Study

    Journal of Gastrointestinal Cancer, 2020

    DOI 10.1007/s12029-020-00514-9 PMID 32914373 4 citations (Europe PMC) Source: OpenAlex

  33. The role of primary tumor resection in patients with stage IV colorectal cancer with unresectable metastases.

    PubMed, 2020

    PMID 32521889 7 citations (Europe PMC) Source: OpenAlex

  34. Predictors of Neoplasia in Colonic Wall Thickening Detected via Computerized Tomography.

    Cureus, 2020

    DOI 10.7759/cureus.10553 PMID 32968607 2 citations (Europe PMC) Open-access full textSource: ORCID

  35. Factors influencing quality of life in cancer patients receiving haemodialysis

    Progress in nutrition, 2020

    DOI 10.23751/pn.v22i2.9210 Open-access full textSource: OpenAlex

  36. Correlation between peripheral blood inflammatory indicators and pathologic complete response to neoadjuvant chemotherapy in locally advanced breast cancer patients

    Medicine, 2020

    DOI 10.1097/md.0000000000020346 PMID 32481414 14 citations (Europe PMC) Open-access full textSource: Europe PMC

  37. Prognostic and Predictive Value of NAR Score in Gastric Cancer

    Journal of Gastrointestinal Cancer, 2020

    DOI 10.1007/s12029-020-00537-2 PMID 33064272 4 citations (OpenAlex) Source: OpenAlex

  38. Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy

    Cureus, 2020

    DOI 10.7759/cureus.7230 PMID 32280572 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  39. Urethral Recurrence of Urothelial Carcinoma of the Bladder Following Radical Cystectomy: An Unusual Imaging Pattern

    Journal of Clinical Imaging Science, 2020

    DOI 10.25259/jcis_7_2020 PMID 33024607 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  40. Investigation of the severity of depressive symptoms in cancer patients receiving chemotherapy

    Eastern Journal of Medicine, 2019

    DOI 10.5505/ejm.2019.02419 Open-access full textSource: ORCID

  41. Investigation of Clinical Features and the Use of Complementary and Alternative Medicines in Cancer Patients, A Single-Center Experience.

    Acta Oncologica Turcica, 2019

    DOI 10.5505/aot.2019.85579 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  42. May High Levels of Systemic Immune-Inflammation Index and Hematologic Inflammation Markers Suggest a Further Stage in Testicular Tumours?

    Urologia Internationalis, 2019

    DOI 10.1159/000502658 PMID 31466076 28 citations (OpenAlex) Source: OpenAlex

  43. Is Tamoxifen Use a Factor Affecting Continence in Breast Cancer Patients?

    Cureus, 2019

    DOI 10.7759/cureus.5417 PMID 31632870 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  44. Local treatment options for management of loco-regional esophageal squamous cell carcinoma

    Romanian Journal of Military Medicine, 2019

    DOI 10.55453/rjmm.2019.122.2.7 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  45. Drug-drug interactions in patients using tyrosine kinase inhibitors: A multicenter retrospective study.

    PubMed, 2019

    PMID 31646831 16 citations (OpenAlex) Source: OpenAlex

  46. Türkiye’de Metastatik Meme Kanserinde HER2 hedefli tedavide Pertuzumab kullanımı erken dönem güvenlilik verileri

    Kocaeli Üniversitesi - AVESİS, 2018

    Source: OpenAlex

  47. Türkiye’xxde metastatik meme kanserinde Her2 hedefli tedavide pertuzumab kullanımı erken dönem güvenlilik verileri

    Kocaeli Üniversitesi - AVESİS, 2018

    Source: OpenAlex

  48. Türkiye'de Metastatik Meme Kanserinde HER-2 Hedefli Tedavide Pertuzumab Kullanımının Erken Dönem Güvenlik Verileri

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source: OpenAlex

  49. Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a retrospective analysis.

    PubMed, 2018

    PMID 30722120 7 citations (Europe PMC) Source: OpenAlex

  50. Metastatik Pankreas Kanserinde 1. Basamakta Gemsitabin ile Gemsitabin ve Sisplatin Kombinasyonunun Karşılaştırması: Çok Merkezli Retrospektif Analiz

    AYBU AVESIS, 2018

    Source: OpenAlex